MASS
What one share of 908 Devices holds
Laboratory Analytical Instruments
We are making chemical analysis simple, smart and speedy with our purpose-built handheld devices that empower people to take swift action in life-altering applications.
908 Devices’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.66 |
|---|---|
| Profit | −$0.94 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | $0.02 |
| Cash and investments | $2.67 |
| Book value | $3.33 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $4.90 | −$2.35 | $0.00 | $0.75 | — | — |
| 2021 | $1.51 | −$0.79 | $0.03 | −$1.07 | — | $6.91 |
| 2022 | $1.49 | −$1.07 | $0.06 | −$0.73 | — | $5.98 |
| 2023 | $1.56 | −$1.13 | $0.06 | −$0.84 | — | $5.09 |
| 2024 | $1.40 | −$2.12 | $0.02 | −$0.91 | — | $3.26 |
| 2025 | $1.57 | $0.54 | $0.03 | −$0.69 | — | $3.96 |